"Inside the Ebola Wars" from The New Yorker, Oct. 27, 2014

This is a report from the Africa side of the Ebola world on the struggles of doctors and their treatment attempts. It details the epidemiological studies and genome mapping of Ebola.

The report names ZMapp as the medicine produced by Kentucky Map BioProcessing labs, as the first medicine that saved Dr. Brantley, whose blood has been since donated to help treat Ebola patients back in the USA.

The report also summarizes vaccines in development, from the National Institutes of Health's testing of a vaccine made by a division of GlaxoSmithKline and based on an adenovirus on twenty volunteers, to one called VSV-EBOV, developed by the Public Health Agency of Canada and licensed to NewLink Genetics, which started human trials last week.

It's long and dramatic, but worth your time. Unlike the rest of media, this is the kind of information that shows us how awesome people in scientific fields are awesomely in the forefront and behind the scenes.

Did I mention that I love the New Yorker?

http://www.newyorker.com/magazine/2014/10/27/ebola-wars